Anteris Competitors

Delisted . USA . 
Stock . Anteris Technologies
Anteris Technologies competes with Ainos, Cellink AB, Bone Biologics, BICO Group, and Brain Scientific; as well as few others. The company classifies itself under Healthcare sector and is part of Medical Devices industry. Analyzing Anteris Technologies competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Anteris Technologies to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Anteris Technologies competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Anteris Technologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details

Anteris Technologies Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Anteris Technologies and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Anteris and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Anteris Technologies does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
TNON
+ 0.53
ASAPF
CLLKF
+ 0.52
AIMDW
BCCOY
+ 0.37
AIMDW
BBLGW
+ 0.34
CLLKF
BBLGW
+ 0.3
AIMDW
BCCOY
+ 0.2
CLLKF
  
High negative correlations   
ASAPF
- 0.74
CLLKF
TNON
- 0.67
AIMDW
TNON
- 0.55
BBLGW
TNON
- 0.54
CLLKF
ASAPF
- 0.41
AIMDW
ASAPF
- 0.3
BBLGW

Risk-Adjusted Indicators

There is a big difference between Anteris Pink Sheet performing well and Anteris Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Anteris Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Anteris Technologies Competitive Analysis

The better you understand Anteris Technologies competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Anteris Technologies' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Anteris Technologies' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AIMDW ARMM CLLKF BBLGW BCCOY BRSF ASAPF TNON
 46.67 
 0.22 
Ainos
 0.00 
 0.0009 
Armm
 8.29 
 3.65 
Cellink
 0.00 
 20.20 
Bone
 0.00 
 0.90 
BICO
 0.00 
 0.75 
Brain
 4.55 
 0.23 
Aurora
 3.60 
 1.34 
Tenon
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Risky
Slightly risky
Abnormally volatile
Very steady
Out of control
Risky
Market Performance
(90 Days Performance)
Solid
Very Weak
OK
Insignificant
Weak
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Above Average
Low
Quite High
Very High
Quite High
Low
Below Average
Very High
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Buy
Trade Advice
(90 Days Macroaxis Advice)
Hold
Strong Sell
Strong Sell
Strong Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
0.53 X
N/A
2.35 X
N/A
2.35 X
0.59 X
2.43 X
7.54 X
Net Asset
31.84 M
N/A
9.75 B
3.86 M
9.75 B
13.38 M
10.56 M
6.34 M
Profit Margin
N/A
N/A
0.02 %
N/A
0.02 %
N/A
(0.11) %
N/A
EBITDA
(8.77 M)
N/A
37.7 M
(4.22 M)
37.7 M
(8.32 M)
(1.9 M)
(15.53 M)
Operating Margin
(359.85) %
N/A
N/A
N/A
N/A
(28.77) %
(0.10) %
(3.62) %
Current Valuation
N/A
N/A
973.88 M
N/A
766.24 M
12.28 M
25.13 M
(711.97 K)
Price To Book
N/A
N/A
1.23 X
N/A
0.63 X
N/A
4.22 X
0.95 X
Retained Earnings
(37.89 M)
N/A
N/A
(85.02 M)
N/A
N/A
N/A
(55.07 M)
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
1.46
N/A
2.1
0.82
2.1
-0.88
0.53
1.9
Number Of Employees
46
2
1.18 K
2
1.18 K
28
4
21
Shares Outstanding
N/A
N/A
69.07 M
N/A
282.3 M
105.4 M
66.73 M
3.14 M
Cash Flow From Operations
(4.69 M)
N/A
(409.2 M)
(4.12 M)
(409.2 M)
(5.87 M)
(2.13 M)
(12.18 M)
Total Debt
5.96 M
N/A
1.35 B
377.71 K
1.35 B
9.97 M
2.27 M
1.86 M
Return On Equity
-0.71
N/A
0.0068
-1.09
0.0068
-45.97
-0.27
-2.56
Z Score
N/A
N/A
N/A
N/A
N/A
18.6
5.4
N/A
Return On Asset
-0.28
N/A
-0.025
-0.53
-0.025
-1.17
-0.0851
-0.84
Book Value Per Share
1.30 X
N/A
N/A
1.81 X
N/A
0.07 X
0.07 X
1.42 X
Number Of Shares Shorted
9.51 K
N/A
N/A
197
N/A
N/A
N/A
172.77 K
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
31.84 M
N/A
9.75 B
3.86 M
9.75 B
13.38 M
10.56 M
6.34 M
Debt To Equity
3.87 %
N/A
0.26 %
N/A
0.26 %
0.18 %
0.58 %
0.07 %
Short Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
2.10 X
Target Price
N/A
N/A
N/A
N/A
N/A
N/A
N/A
8.0
Shares Owned By Institutions
N/A
N/A
26.80 %
N/A
N/A
18.54 %
N/A
4.19 %
Market Capitalization
N/A
N/A
657.9 M
N/A
654.31 M
316.21 M
21.68 M
4.2 M
Price To Earning
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
N/A
N/A
4.61 X
N/A
2.37 X
26.56 X
1.70 X
1.27 X
Net Income
(13.77 M)
N/A
(227.6 M)
(4.11 M)
(227.6 M)
(9.1 M)
(2.36 M)
(15.58 M)
Earnings Per Share
N/A
N/A
0.06 X
(0.14) X
0.01 X
(0.29) X
(0.04) X
287.92 X
Shares Owned By Insiders
N/A
N/A
38.50 %
N/A
N/A
23.83 %
17.89 %
1.63 %
Revenue
122.11 K
N/A
1.26 B
N/A
1.26 B
265.75 K
10.54 M
2.93 M
Working Capital
1.14 M
N/A
N/A
2.91 M
N/A
N/A
N/A
6.82 M
Cash And Equivalents
1.87 M
N/A
N/A
4.44 K
N/A
3.54 M
758.98 K
16.02 M
Cash Per Share
0.19 X
N/A
N/A
N/A
N/A
0.03 X
0.01 X
1.42 X
Gross Profit
(143.35 K)
N/A
1.03 B
N/A
1.03 B
83.23 K
4.83 M
1.92 M
Day Typical Price
0.24
9.0E-4
3.65
20.2
0.9
0.75
0.23
1.36
Accumulation Distribution
0.62
N/A
N/A
N/A
N/A
N/A
0.0417
0.05
Market Facilitation Index
0.23
N/A
N/A
N/A
N/A
N/A
0.01
0.07
Daily Balance Of Power
0.3043
0.0
(9,223,372,036,855)
0.0
0.0
0.0
1.0
(0.71)
Period Momentum Indicator
0.07
N/A
(0.33)
N/A
N/A
N/A
0.01
(0.05)
Rate Of Daily Change
1.47
1.0
0.92
1.0
1.0
1.0
1.05
0.96
Day Median Price
0.26
9.0E-4
3.65
20.2
0.9
0.75
0.24
1.37
Price Action Indicator
N/A
N/A
(0.17)
N/A
N/A
N/A
N/A
(0.05)
Relative Strength Index
57.04
N/A
87.7
38.05
52.78
N/A
30.31
29.52
Coefficient Of Variation
468.88
N/A
1097.52
785.42
3628.99
N/A
(851.02)
(401.95)
Mean Deviation
25.92
N/A
2.05
13.02
0.8075
N/A
2.44
2.67
Jensen Alpha
8.53
N/A
0.3766
3.68
0.1513
N/A
(0.45)
(0.97)
Total Risk Alpha
9.62
N/A
0.4942
4.46
0.2305
N/A
(0.33)
(0.84)
Sortino Ratio
0.3111
N/A
0.0494
0.1207
N/A
N/A
N/A
N/A
Downside Variance
731.78
N/A
61.91
892.56
N/A
N/A
N/A
N/A
Standard Deviation
39.4
N/A
4.12
28.22
4.09
N/A
3.68
3.8
Kurtosis
5.61
N/A
5.11
21.1
35.77
N/A
2.49
4.1
Potential Upside
89.13
N/A
8.49
31.15
N/A
N/A
4.55
5.33
Treynor Ratio
1.38
N/A
0.7622
0.8267
0.0487
N/A
1.76
1.58
Maximum Drawdown
218.95
N/A
22.01
237.6
26.76
N/A
22.71
26.68
Variance
1551.98
N/A
16.99
796.2
16.75
N/A
13.55
14.46
Market Risk Adjusted Performance
1.39
N/A
0.7722
0.8367
0.0587
N/A
1.77
1.59
Risk Adjusted Performance
0.1669
N/A
0.0753
0.1035
0.0285
N/A
(0.08)
(0.18)
Skewness
2.05
N/A
0.3715
2.88
2.68
N/A
0.4641
0.8818
Semi Deviation
16.6
N/A
2.74
17.54
N/A
N/A
N/A
N/A
Information Ratio
0.2136
N/A
0.0943
0.1278
0.0307
N/A
(0.11)
(0.25)
Value At Risk
(41.86)
N/A
(8.06)
(20.09)
N/A
N/A
(6.45)
(5.43)
Expected Short fall
(52.40)
N/A
(7.13)
(21.31)
N/A
N/A
N/A
N/A
Downside Deviation
27.05
N/A
7.87
29.88
N/A
N/A
N/A
N/A
Semi Variance
275.47
N/A
7.5
307.76
N/A
N/A
N/A
N/A

Anteris Technologies Competition Performance Charts

JavaScript chart by amCharts 3.21.15Dec2025FebJan 17Jan 22Jan 27FebFeb 06Feb 11Feb 16Feb 21Feb 26-50%0%50%100%150%200%250% Show all
JavaScript chart by amCharts 3.21.15Ainos Inc Armm Inc Cellink AB Bone Biologics Corp BICO Group AB Brain Scientific Aurora Spine Tenon Medical Dow Jones Industrial

Five steps to successful analysis of Anteris Technologies Competition

Anteris Technologies' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Anteris Technologies in relation to its competition. Anteris Technologies' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Anteris Technologies in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Anteris Technologies' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Anteris Technologies, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Anteris Technologies position

In addition to having Anteris Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Macroaxis Picks Thematic Idea Now

Macroaxis Picks
Macroaxis Picks Theme
Daily selected watch list of stocks of large companies handpicked by Macroaxis Team based on their diversification potential. The Macroaxis Picks theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Picks Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in Anteris Pink Sheet

If you are still planning to invest in Anteris Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anteris Technologies' history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Valuation
Check real value of public entities based on technical and fundamental data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY